BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35561289)

  • 1. Financial Impact of Medically Integrated Pharmacy Interventions on Oral Oncolytic Prescriptions.
    Darling JO; Starkey AJ; Nubla JJ; Reff MJ
    JCO Oncol Pract; 2022 Jul; 18(7):e1225-e1230. PubMed ID: 35561289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial impact from in-office dispensing of oral chemotherapy.
    Howard A; Kerr J; McLain M; Modlin J
    J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review.
    Wink S; Schroader BK; Giglio T; Ward A
    J Oncol Pharm Pract; 2024 Jul; 30(5):884-892. PubMed ID: 37649402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of costs of community and mail service pharmacy.
    Carroll NV; Brusilovsky I; York B; Oscar R
    J Am Pharm Assoc (2003); 2005; 45(3):336-43. PubMed ID: 15991755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
    Carroll NV
    J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Medically Integrated Dispensing Among Oncology Practices.
    Kanter GP; Parikh RB; Fisch MJ; Debono D; Bekelman J; Xu Y; Schauder S; Sylwestrzak G; Barron JJ; Cobb R; Qato DM; Jacobson M
    JCO Oncol Pract; 2022 Oct; 18(10):e1672-e1682. PubMed ID: 35830621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recycling unused medications in hospitals is financially viable and good for the environment.
    Drummond I; Bains R; Dosanjh A; Ladhar S; Tang L; Heidary D; Tejani AM
    Int J Pharm Pract; 2023 Sep; 31(5):562-564. PubMed ID: 37566550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidance on Implementing an Oral Chemotherapy Drug Repository Program in a Medically Integrated Pharmacy Setting.
    Monestime S; Magallon T; Jenkins L; Page R
    JCO Oncol Pract; 2021 Jul; 17(7):e448-e453. PubMed ID: 33900790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient perspectives of antiretroviral pharmacy services: A cross-sectional cohort study.
    Liu Y; Lyden E; Furl R; Havens JP
    PLoS One; 2023; 18(5):e0285694. PubMed ID: 37220118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
    Herrier RN; Spencer JR; Davis CD
    J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.
    Royce TJ; Schenkel C; Kirkwood K; Levit L; Levit K; Kircher S
    JCO Oncol Pract; 2020 May; 16(5):276-284. PubMed ID: 32310720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic dispensing and substitution in mail and retail pharmacies.
    Wosinska M; Huckman RS
    Health Aff (Millwood); 2004; Suppl Web Exclusives():W4-409-16. PubMed ID: 15451951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of 90-day prescriptions on adherence at workplace pharmacies compared to traditional mail order.
    Patwardhan A; Davis J; Murphy P; Khandelwal N; Sherman B; Manfred J
    Popul Health Manag; 2011 Dec; 14(6):285-91. PubMed ID: 22092153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How might the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 affect the financial viability of rural pharmacies? An analysis of preimplementation prescription volume and payment sources in rural and urban areas.
    Fraher EP; Slifkin RT; Smith L; Randolph R; Rudolf M; Holmes GM
    J Rural Health; 2005; 21(2):114-21. PubMed ID: 15859048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.